Diagnostic Evolution: How Early Detection is Scaling the US$ 4.6 Million Acute Intermittent Porphyria Market
Acute Intermittent Porphyria (AIP), the most common and severe form of acute hepatic porphyria, is undergoing a clinical shift from reactive crisis management to proactive, genetic-level...